WASHINGTON — The Food and Drug Administration says its ongoing safety review of the nation’s main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug’s use curtailed ... .
Bank of EnglandChief Economist Huw Pill urges central banks to prioritise inflation control amid rising global bond yields. Divisions among UK policymakers over interest rates persist as they assess inflation risks linked to the Iran war ... .
In an expected turn of events on Wednesday, the Trump administration provided its on its needless re-review into the abortion pill and revealed… nil ... of two pills taken in a medication abortion.
More than 10,000 bottles have sold in the past month, with thousands of reviewers praising the pills for their “miraculous” gut health benefits ... Then they tried the Zenwise pills ... The brand recommends taking two pills daily before meals.
The drug significantly reduced the amount of time patients spent struggling with the stiffness, slowness and tremors associated with the condition ....
A federal judge in Louisiana ordered the agency to provide an update on its safety study as part of a lawsuit seeking to overturn a provision allowing mifepristone to be delivered by mail ... .